IL17A and asthma: In cutaneous fungal infections, older age, history of asthma, and use of IL‐17 inhibitors had a significantly higher OR than others (1.034, 95% CI 1.011–1.058, p = 0.0032; 2.286, 95% CI 1.026–5.095, p = 0.0432; and 3.137, 95% CI 1.705–5.772, p = 0.0002, respectively) (Table 5).